Guiling prescription attenuates hyperuricemia via multi-target regulation of uric acid metabolism, renal protection, and inflammation: insights from metabolomics and network pharmacology. [PDF]
Wang Y +7 more
europepmc +1 more source
Transporter-Mediated Interactions Between Uremic Toxins and Drugs: A Hidden Driver of Toxicity in Chronic Kidney Disease. [PDF]
Spicher P +6 more
europepmc +1 more source
Understanding Pharmacokinetic-Drug Interactions With Drugs Approved by the US Food and Drug Administration in 2024 to Better Manage the Risk of Drug Interactions With Concomitant Medications: A Review of Clinical Data From New Drug Applications. [PDF]
Yu J +4 more
europepmc +1 more source
<i>Lactobacillus paracasei</i> N1115 alleviates hyperuricemia in mice: regulation of uric acid metabolism as well as its impact on gut microbiota and short-chain fatty acids. [PDF]
Zhang H +7 more
europepmc +1 more source
A novel Chinese medicine formula against hyperuricemia-induced kidney inflammation involving pyroptosis inhibition via modulating AMPK-TLR4-NLRP3 pathway. [PDF]
Tian YY +5 more
europepmc +1 more source
Putative new biomarkers for renal transporter-mediated drug-drug interactions: Characterization as substrates of organic cation transporter 2, multidrug and toxin extrusion protein 1, and other important drug transporters. [PDF]
Gessner A +5 more
europepmc +1 more source
Complex interactions of gut-derived short-chain fatty acids in hyperuricemia and gout pathophysiology. [PDF]
Cui Y +5 more
europepmc +1 more source
Clinical Pharmacokinetics and Pharmacodynamics of Lenalidomide [PDF]
Maria Palmisano +2 more
core +1 more source
Genome-wide association studies and traditional Chinese medicine in hyperuricemia: current evidence and mechanistic insights. [PDF]
Yang L, Liu J, Luo S, Deng Y.
europepmc +1 more source

